Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma

Published:2019-07-01 Issue:7 Volume:5 Page:985
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Fakhry Carole¹²,Blackford Amanda L.³,Neuner Geoff⁴,Xiao Weihong⁵,Jiang Bo⁵,Agrawal Amit⁶,Gillison Maura L.⁵

Affiliation:

1. Department of Otolaryngology–Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland

2. Johns Hopkins Bloomberg Kimmel Institute of Immunotherapy, Baltimore, Maryland

3. Sidney Kimmel Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland

4. Department of Radiation Oncology, Greater Baltimore Medical Center, Baltimore, Maryland

5. Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

6. Department of Otolaryngology–Head and Neck Surgery, The Ohio State University, Columbus

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/5/7/985/17712466/jamaoncology_fakhry_2019_oi_190017.pdf

Reference38 articles.

1. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients.;Castellsagué;J Natl Cancer Inst,2016

2. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.;Fakhry;J Natl Cancer Inst,2008

3. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.;Fakhry;Cancer,2017

4. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.;Ang;J Clin Oncol,2014

5. NCCN Guidelines insights: head and neck cancers, version 1.2018.;Colevas;J Natl Compr Canc Netw,2018

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?;Discover Oncology;2024-09-11

2. The Role of Biomarkers in HPV-Positive Head and Neck Squamous Cell Carcinoma: Towards Precision Medicine;Diagnostics;2024-07-07

3. Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management;Journal of Medical Virology;2024-06

4. The molecular characteristics of recurrent/metastatic HPV‐positive head and neck squamous cell carcinoma: A systematic review of the literature;Clinical Otolaryngology;2024-04-24

5. Reappraisal of p16 for Determining HPV Status of Head and Neck Carcinomas Arising in HPV Hotspots;American Journal of Surgical Pathology;2024-03-14